TREM-1 protein and severe alcoholic hepatitis outlook
Part of Digestive system, Mental health clinical trials.
This study looks at a protein called TREM-1 in liver tissue to see if it might predict how severe alcoholic hepatitis progresses. It analyzes stored liver samples from patients to understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for severe alcohol-related hepatitis at CHRU de Nancy between 2013 and 2023.
- You have archived liver biopsy slides available at the hospital.
- You are an adult (18 or older).
- You agreed to let your data be used for this research.
- This does not apply if you are a control participant (treated for certain liver cancers or colorectal liver metastases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic differences in people with alcohol-related liver illness, including a recent jaundice episode (alcoholic hepatitis). By following people over time, it may help doctors better predict illness and understand why some people develop worse liver problems.
This trial looks at the gut bacteria (microbiome) in people with severe alcoholic hepatitis to understand how it affects the illness. It may help doctors find better ways to treat this condition.
This trial tests a new medicine called MRG-001 for people with severe alcoholic hepatitis, a liver condition caused by heavy drinking. The study aims to see if the drug can help improve liver function and reduce symptoms.
This study follows people with severe alcoholic hepatitis who are being considered for an early liver transplant before they’ve been sober for 6 months. It aims to better understand this group’s situation and ethics/safety as early transplantation plans are made.
This trial is looking at bacteria inside the liver of people with alcoholic hepatitis. It may help understand how these bacteria affect the disease and lead to better treatments.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
Hear when a new Severe Alcoholic Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.